Tech Company Inital Public Offerings
Acceleron Pharma IPO
Headquartered in Cambridge, Acceleron Pharma is now a public company.
Transaction Overview
Company Name
Announced On
9/19/2013
Transaction Type
IPO
Amount
$84,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
128 Sidney St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body's remarkable capacity for cellular growth and repair.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Habib Dable
Chief Financial Officer
Kevin McLaughlin
Chief Scientific Officer
Ravi Kumar
Vice President
Todd James
VP - Bus. Development
Sujay Kango
VP - Bus. Development
John Quisel
VP - Bus. Development
Tracey Sacco
VP - General Counsel
Adam Veness
VP - Human Resources
Kevin McManus
VP - Regulatory Affairs
James Desiderio
Browse more venture capital transactions:
Prev: 9/19/2013: App Annie venture capital transaction
Next: 9/19/2013: Travefy venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs